Sotera Health
SHC | NASDAQ
$18.91
+$0.21 (+1.12%)
Sep 22, 2026, 10:22 AM ET · Market open
Market Data
Market Cap $5.33B
Enterprise Value $7.24B
Beta 1.78
Average Volume 3.16M
Shares Outstanding (Diluted) 288.15M
Shares Change YoY 0.84%
Institutional Ownership 96.74%
Exchange NASDAQ
ISIN US83601L1026
Price Performance
Price Change 1M -4.0%
Price Change 3M 18.1%
Price Change 6M 36.5%
Price Change YTD 5.7%
Price Change 1Y 15.9%
Price Change 3Y 21.6%
Price Change 5Y -28.5%
1M CAGR (ann.) -0.8%
1Y CAGR (ann.) 17.1%
5Y CAGR (ann.) -5.6%
All-Time CAGR -4.9%
Valuation
PE Ratio 32.81
Forward PE 17.40
PEG Ratio 0.06
Forward PEG 3.56
PS Ratio 4.38
Forward PS 4.00
PB Ratio 8.01
P/FCF Ratio 55.56
P/Adj. FCF Ratio 119.97
P/OCF Ratio 18.33
EV/Sales 5.96
EV/EBIT 17.78
EV/EBITDA 13.43
EV/FCF 75.48
Earnings Yield 3.0%
FCF Yield 1.8%
Adj. FCF Yield 0.8%
Financial Health
Net Debt $1.91B
Total Debt $2.27B
Cash & Short-Term Investments $356.73M
Total Assets $3.31B
Current Ratio 2.80
Quick Ratio 2.53
Debt / Equity Ratio 3.41
Debt / EBITDA 4.20
Debt / FCF 23.63
OCF / Debt 0.14
Interest Coverage 3.07
Altman Z-Score 1.95
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 54.7%
Operating Profit Margin 36.2%
EBITDA Margin 44.4%
Net Profit Margin 13.4%
FCF Margin 7.9%
Adj. FCF Margin 3.6%
SBC / Revenue 3.0%
SBC Impact (per share) -53.7%
Returns
Return on Assets 4.9%
Return on Equity 26.8%
Return on Invested Capital 8.8%
Return on Capital Employed 14.3%
Return on Tangible Assets 8.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.6%
Revenue CAGR 5Y 6.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 81.2%
EPS CAGR 5Y 95.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 39.9%
FCF CAGR 5Y -5.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 30.6%
Revenue Growth Next 3Y 6.8%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.27
EPS Growth Est (next Q) 3.9%
Revenue Est (next Q) $319.84M
Revenue Growth Est (next Q) 2.7%
Fair Value Estimates
Graham Number $5.47
Graham Upside -70.8%
Lynch Fair Value $14.25
Lynch Upside -23.8%
Price Target $20.50
Price Target Upside 9.6%
Cash Flow
Operating Cash Flow $321.62M
Free Cash Flow $95.97M
Adj. Free Cash Flow $44.45M
FCF Per Share $0.39
OCF Per Share $1.02
OCF/S Ratio 24.0%
Income Statement
Revenue $1.22B
Gross Profit $665.48M
Operating Income $440.73M
EBITDA $539.39M
Net Income $163.48M
EPS (Diluted) $0.57
Revenue / Employee $405.39K
Profit / Employee $54.49K
Employees 3,000
Add to Watchlist
Select watchlists to add or remove SHC